-
The Defibrillator Market report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027.
The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global defibrillator market report has been segmented on the basis of product type, end-user, and region.
Defibrillator Market Report Overview:
“The Defibrillator Market size is expected to be worth around US$ 19 Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of 6.5% during the forecast period 2021 to 2031.”
A defibrillator is a device that delivers high electric shocks, the procedure is used to treat life-threatening conditions such as ventricular fibrillation, pulseless ventricular tachycardia, and cardiac arrhythmia. There are different types of defibrillators available on market such as implanted defibrillators and external defibrillators. Defibrillators are easy to use, portable, fully automated, and user-friendly.
Defibrillators are available in public places and hence it is also known as public access defibrillators. It helps in increasing the survival rate from sudden cardiac arrest. A defibrillator provides a number of benefits such as continuous monitoring of heart rhythms, provides protection, and acts as a lifesaving therapy.
The increasing incidence of cardiovascular diseases globally is expected to fuel the growth of the global defibrillator market over the forecast period. Moreover, the growing geriatric population coupled with the risk of getting cardiac diseases is expected to contribute to the market growth.
Furthermore, technological advancements and innovations in defibrillators and increasing awareness regarding the use of the device are expected to drive the global defibrillator market over the forecast period.
However, manufacturers can develop defibrillators that can minimize the risk of infection, allergic reaction, and vein damage which is expected to create new opportunities for existing as well as a new market entrants in the global defibrillator market over the forecast period.
North American market dominates the global defibrillator market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of well-developed healthcare infrastructure and favorable reimbursement schemes in the region.
Europe accounts for the second-largest revenue share contribution to the global defibrillator market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively.
The market in Europe is projected to register comparatively faster growth in terms of revenue over the next 10 years owing to the increasing incidence of cardiovascular diseases and increasing awareness of defibrillators in the region.
Global defibrillator market segmentation, by product type:
- Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
- Single Chamber
- Dual Chamber
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
- Transvenous Implantable Cardioverter Defibrillators
- External Defibrillator
- Automated External Defibrillators (AEDS)
- Manual External Defibrillators
- Wearable Cardioverter Defibrillators (WCDS)
Global defibrillator market segmentation, by end user:
- Hospital
- Prehospital
- Public Access Market
- Alternate Care Market
- Home Healthcare
Global defibrillator market segmentation, by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Implantable Cardioverter Defibrillators
-
- Medtronic Plc.
- Boston Scientific Corporation
- LivaNova Plc.
- Koninklijke Philips N.V.
- Zoll Medical Corporation
- Defibtech, LLC.
- Biotronik SE & Co. KG
- Schiller AG
- HeartSine Technologies, LLC.
- Physio-Control, Inc.
-
Request for TOC
-
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!